Our history

mi-BiomarK was conceived from a critical necessity: the early detection and effective monitoring of pancreatic cancer. Witnessing the pressing demand for improved diagnostic tools in the fight against this disease, our company embarked on a journey fueled by innovation and dedication.

​

With a clear vision to revolutionize early diagnosis and follow-up care for pancreatic cancer patients, mi-BiomarK emerged as a potential solution in the medical landscape. Our journey began with a challenge in class, that soon after became a profound commitment to research, looking for collaboration with leading experts and institutions to pioneer breakthrough solutions.

​

Join us in our mission as we redefine possibilities and pave the way toward a future where early detection and personalized care are not just aspirations, but realities for all.